BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27583690)

  • 21. Editorial commentary: Peripartum cardiomyopathy: Long-term implications of treatment and management.
    Haghikia A; Hilfiker-Kleiner D
    Trends Cardiovasc Med; 2019 Apr; 29(3):174-175. PubMed ID: 30219276
    [No Abstract]   [Full Text] [Related]  

  • 22. A de-novo deletion of dystrophin provoking severe 'peri-partum cardiomyopathy': The importance of genetic testing in peripartum cardiomyopathy to uncover female carriers.
    Ahmed A; Spinty S; Murday V; Longman C; Khand A
    Int J Cardiol; 2016 Jan; 203():1084-5. PubMed ID: 26651149
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripartum Cardiomyopathy: Is It All in the Timing?
    Roth Flach RJ; Khankin EV
    Hypertension; 2020 Jan; 75(1):33-34. PubMed ID: 31707839
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripartum Cardiomyopathy.
    Cunningham FG; Byrne JJ; Nelson DB
    Obstet Gynecol; 2019 Jan; 133(1):167-179. PubMed ID: 30575651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
    Fett JD
    Eur Heart J; 2018 Nov; 39(43):3904. PubMed ID: 30272149
    [No Abstract]   [Full Text] [Related]  

  • 26. Peripartum cardiomyopathy - from pathogenesis to treatment.
    Jagodzińska A; Gondek A; Pietrzak B; Cudnoch-Jędrzejewska A; Mamcarz A; Wielgoś M
    J Perinat Med; 2018 Apr; 46(3):237-245. PubMed ID: 28489560
    [No Abstract]   [Full Text] [Related]  

  • 27. Earlier Diagnosis of Peripartum Cardiomyopathy (PPCM).
    Fett JD
    Circ J; 2020 Aug; 84(9):1672. PubMed ID: 32713882
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to '12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy'.
    Hoevelmann J; Viljoen CA; Millar RS; Manning K; Ntsekhe M; Sliwa K
    Int J Cardiol; 2019 Dec; 297():91. PubMed ID: 31431295
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial Damage in an Elderly Female Patient With Peripartum Cardiomyopathy.
    Kawano H; Matsumura K; Sueyoshi E; Koga S; Ikeda S; Maemura K
    Circ J; 2021 Jun; 85(7):1102. PubMed ID: 33980781
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid metabolism in peripartum cardiomyopathy.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2021 Mar; 18(3):150. PubMed ID: 33349667
    [No Abstract]   [Full Text] [Related]  

  • 31. Readmissions Among Patients With Peripartum Cardiomyopathy.
    Çelik O; Çil C; Biteker FS; Biteker M
    Am J Cardiol; 2018 Sep; 122(5):911. PubMed ID: 30049461
    [No Abstract]   [Full Text] [Related]  

  • 32. Response by Arany and Elkayam to Letter Regarding Article, "Peripartum Cardiomyopathy".
    Arany Z; Elkayam U
    Circulation; 2016 Aug; 134(7):e83-4. PubMed ID: 27528651
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter by Dalzell et al Regarding Article, "Peripartum Cardiomyopathy".
    Dalzell JR; Barton AK; McKeag NA
    Circulation; 2016 Aug; 134(7):e81-2. PubMed ID: 27528650
    [No Abstract]   [Full Text] [Related]  

  • 34. A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hoevelmann J; Engel ME; Muller E; Hohlfeld A; Böhm M; Sliwa K; Viljoen C
    Eur J Heart Fail; 2022 Sep; 24(9):1719-1736. PubMed ID: 35778990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
    Ersbøll AS; Arany Z; Gustafsson F
    Eur Heart J; 2018 Oct; 39(37):3476-3477. PubMed ID: 30016425
    [No Abstract]   [Full Text] [Related]  

  • 36. New Insights in Peripartum Cardiomyopathy.
    Cruz MO; Briller J; Hibbard JU
    Obstet Gynecol Clin North Am; 2018 Jun; 45(2):281-298. PubMed ID: 29747731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Eur Heart J; 2018 Nov; 39(43):3905. PubMed ID: 30272152
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripartum cardiomyopathy, place of drug therapy, assist devices, and outcome after left ventricular assistance.
    Hamdan R; Nassar P; Zein A; Issa M; Mansour H; Saab M
    J Crit Care; 2017 Feb; 37():185-188. PubMed ID: 27776335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?
    Elkayam U; Habakuk O
    JACC Heart Fail; 2016 May; 4(5):389-91. PubMed ID: 27126284
    [No Abstract]   [Full Text] [Related]  

  • 40. Peripartum cardiomyopathy: a single institution 5-yr experience.
    Elsamragy S; Babazade R; Simon M; Ibrahim M; Vadhera RB
    Br J Anaesth; 2019 Oct; 123(4):e491-e493. PubMed ID: 31443917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.